CSIMarket
 
Geovax Labs Inc   (NASDAQ: GOVX)
 

Geovax Labs Inc's Suppliers Performance

GOVX's Supply Chain




 
GOVX Costs vs Sales of Suppliers Growth

• More on GOVX Suppliers






Geovax Labs Inc's Comment on Supply Chain


GeoVax utilizes raw materials and supplies from multiple commercial suppliers for vaccine manufacturing and research. The company is transitioning from using primary chicken embryonic fibroblast (CEF) cultures derived from SPF eggs to a continuous cell-line manufacturing process for MVA-based vaccines. In September 2023, GeoVax entered into a commercial, multi-product license agreement with ProBioGen for the AGE1.DR.piX® (AGE1) suspension avian cell line, a validated continuous cell-line platform designed for scalable, serum-free, suspension-based manufacturing in bioreactors. This transition is intended to improve manufacturing yields, reduce costs, and increase flexibility. GeoVax has completed cGMP manufacture and fill-finish of clinical-grade GEO-MVA material and is advancing continuous cell-line manufacturing strategies, although further development, validation, regulatory review, and investment are required for full implementation.

Geovax Labs Inc's Comment on Supply Chain


GeoVax utilizes raw materials and supplies from multiple commercial suppliers for vaccine manufacturing and research. The company is transitioning from using primary chicken embryonic fibroblast (CEF) cultures derived from SPF eggs to a continuous cell-line manufacturing process for MVA-based vaccines. In September 2023, GeoVax entered into a commercial, multi-product license agreement with ProBioGen for the AGE1.DR.piX® (AGE1) suspension avian cell line, a validated continuous cell-line platform designed for scalable, serum-free, suspension-based manufacturing in bioreactors. This transition is intended to improve manufacturing yields, reduce costs, and increase flexibility. GeoVax has completed cGMP manufacture and fill-finish of clinical-grade GEO-MVA material and is advancing continuous cell-line manufacturing strategies, although further development, validation, regulatory review, and investment are required for full implementation.







GOVX's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Geovax Labs Inc 1.60 5.59 -20.43 19
SUBTOTAL 0.00 0.00 0.00 -


Sources: Geovax Labs Inc 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Geovax Labs Inc ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.